General Information
Revision date
2016-04-04
Product name
Quinn’s Advantage Serum Protein Supplement (SPS)
1.2.1 Relevant identified uses
SAGE In Vitro Fertilization
Manufacturer Name
SAGE In Vitro Fertilization
Icons in SDS
Company Information
company name
SAGE In Vitro Fertilization
Section 2
SECTION 2: Hazards identification
Product contains 50 mg/mL human serum protein, a derivative of plasma and a potentially bio-hazardous material. The proteins used in this product were derived from plasma which was collected from centers located in the United States and licensed by the United States Food and Drug Administration. Each individual plasma unit has been tested by FDA approved methods and found to be non-reactive for hepatitis B surface antigen (HBsAg) and antibodies to hepatitis C virus (HCV) and human immunodeficiency virus (HIV) by approved testing methods. Donors of the source material have been screened for Creutzfeldt- Jakob disease (CJD). Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases. A theoretical risk for transmission of CJD is also considered extremely remote. No cases of transmission of viral disease or CJD have ever been identified for plasma.
